Free Trial

Allergan (AGN) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
30 Most Miserable Countries in the World
teva logo on glass table with vials of liquid
6 reasons to buy Teva Pharmaceuticals stock sooner than later (AGN)
Investors seeking a long-term and undervalued pharmaceutical play should take a close look at Teva Pharmaceuticals, and here are six reasons why
Bausch + Lomb posts better than expected Q2 earnings
Why Valeant Pharmaceuticals (VRX) Stock Is Up
Virios Therapeutics stock price
Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal (AGN)
Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Is the Pain Over for Baudax Bio Investors after a 70% Spike? (AGN)
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.
Is AbbVie a Buy? - Nasdaq
Get Allergan News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter.

Fed's New Power to Seize Bank Accounts (Ad)

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

AGN Media Mentions By Week

AGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGN
News Sentiment

0.00

0.74

Average
Medical
News Sentiment

AGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGN Articles
This Week

0

0

AGN Articles
Average Week

Get Allergan News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:AGN) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners